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1. Introduction 
Pheochromocytoma is a rare catecholamine secreting tumor of the chromaffin of the body 
derived from the neural crest tissue and accounts for 0.1% to 1% of all cases of chronic 
hypertension (Manger et al, 1985). The common presenting signs and symptoms are 
paroxysmal hypertension, headache, excessive sweating, and palpitation. The hypertension 
is episodic in nature in up to 50% of cases. Also, 10% of patients remain normotensive 
(Bravo & Gifford, 1984). Thus, pheochromocytoma may go unrecognized and up to 50% of 
the cases are diagnosed only at postmortem examination. A proportion of patients are 
diagnosed at the time of incidental surgery, when induction of anesthesia and surgical 
manipulations may precipitate catastrophic hemodynamic crisis and even multiple organ 
failure (Siddik-Sayyid et al. 2007; Dabbous et al.2007; O’Riordan JA, 1997). In this situation, 
mortality is close to 80% (O’Riordan, 1997). The dramatic improvement in surgical outcome 
of diagnosed pheochromocytoma can be attributed to adequate preoperative imaging, 
appropriate medical preparation, and improved surgical and anesthetic techniques (Schiff & 
Welsh, 2003).  
2. Pheochromocytoma the “10% tumor” 
Pheochromocytoma has been referred to as the “10% tumor” because 10% are extraadrenal, 
10% are malignant, 10% bilateral, 10% in children, and finally 10% are hereditary. The extra-
adrenal tumors are more likely to be multiple and malignant. 
3. Plasma catecholamines 
Plasma adrenaline concentrations >400 pg/ml, and plasma noradrenaline concentrations> 
1000 pg/ml are generally diagnostic of pheochromocytoma. However, there is no significant 
correlation between the plasma catecholamine levels and the degree of hypertension. This 
may be attributed to different factors such as the decreased blood volume in the 
pheochromocytoma patient, the episodic secretion of catecholamines, the associated down 
regulation of the adrenergic receptors, as well as the paroxysmal attacks of hypertension. 
The presence of normotension despite an increased plasma concentration of catecholamines 
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presumably reflects a decrease in the number of alpha-adrenergic receptors (down 
regulation) in response to increased circulating concentration of the neurotransmitter. 
Clonidine (0.3mg orally, suppresses the plasma concentrations of catecholamines in a 
hypertensive patient but not in the pheochromocytoma patient.  Clonidine acts as ┙2-
adrenergic agonist and hence can suppress an increase in the plasma catecholamine 
resulting from neurogenic release, but not secondary to diffusion of excess catecholamines 
from a pheochromocytoma into the circulation (Bravo & Gifford, 1984) 
4. Preoperative preparation 
Patients with pheochromocytoma are chronically vasoconstricted as a result of the high 
levels of circulating catecholamines, and have a secondary decrease in their blood volume. 
Preparation for surgery in patients with diagnosed pheochromocytoma should begin at least 
2 weeks preoperatively to allow full alpha-adrenergic blockade along with the gradual 
restoration of blood volume. A standard protocol for adrenergic blockade is to administer 
phenoxyhenzamine, starting at a dose of 40mg per day, and gradually increasing to 80-120 
mg per day. This single precaution may decrease perioperative mortality down from 43% to 
3%. The most common side effect of phenoxybenzamine is postural hypotension. Beta-
blockade can be given after starting alpha-blockade, if tachycardia or other arrhythmias 
develop. Beta-blockers must never be started prior to adequate alpha-blockade, since in the 
absence of beta2 mediated vasodilation, profound unopposed alpha-mediated 
vasoconstriction may lead to hypertensive crisis or pulmonary edema (MyKlejard, 2004; 
Kinney et al. 2002; O’Riordan, 2007; Geogheghan et al. 1998).  
Whereas norepinephrine released from sympathetic nerve fibers activates the junctional ┙1-
adrenergic receptors, it is thought that the ┙2-receptors are extrajunctional, and are 
preferentially stimulated by circulating catecholamines (Hamdan & Limbird, 1996). Also the 
┙2-receptors are located prejunctional and function as a negative feedback. Despite its 
selective ┙1-receptor antagonist effect, prazosin has little or no ┙2-receptor blocking effect at 
concentrations achieved clinically (Hamdan & Limbird, 1996). Nicholson and colleagues 
found that pheochromocytoma patients pretreated with prazosin exhibited marked 
hypertensive responses to tumor handling requiring phentolamine (Nicholson et al. 1983). 
In another study by Russel and colleagues, phenoxybenzamine, which is a nonselective ┙1 
and ┙2-receptor blocker, provided superior intraoperative stability compared to prazosin 
(Russell et al. 1998). Also, in contrast to phenoxybenzamine, prazosin has a short elimination 
half-life (2-3 hours); therefore prazosin blood concentrations may decrease to ineffective 
levels at the time of surgery (Prys-Roberts, 2000). 
Prys-Roberts suggested that doxazosin, a long-acting and selective ┙1-adrenergic blocking 
agent is preferable to phenoxybenzamine when used in the dose range 2-8 mg/day. He 
suggests that because doxazosin does not block ┙2-adrenergic activity, many patients do not 
require ┚-adrenergic blocking agents. The selective ┙1-antagonsist prazosin and doxazosin 
have been used in the management of pheochromocytoma. They do not block the 
presynaptic ┙2-adrenergic receptors; thus by allowing norepinephrine reuptake by nerve 
endings, the tachycardia following the administration of the nonselective ┙1 and ┙2 
adrenergic blocker phenoxybenzamine does not occur. However, it has the disadvantage of 
being long-acting and the patient may develop postoperative hypotension refractory to 
norepinephrine (Nicholson et al.,1983; Hull, 1986). To help assess the adequacy of 
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preoperative management of pheochromocytoma, the following Roizen criteria should be 
met in order to reduce perioperative morbidity and mortality (Table 1) (Roizen et al., 1982). 
 
_________________________________________________________________________________ 
Roizen et al proposed treatment for at least 10 days and until: 
1. There are no marked symptoms 
2. Arterial blood pressure does not exceed 160/90 mmHg on more than four 
measurements in 24hr 
3. Systolic blood pressure has decreased by at least 15% when moving from lying to 
standing position, but was more than 80/45 mmHg 
4. The ECG was free of changes in ST segment and T wave for 2 weeks 
_________________________________________________________________________________ 
Table 1. Preoperative Preparation 
There is no accepted rule regarding the duration of adequate preoperative preparation; 
however, the study of Russels et al suggested that 5-7 days will be generally sufficient. MFH 
James practice is to increase ┙-blockade on a daily basis until adequate hemodynamic 
control is achieved and then to proceed to surgery, rather than use any predetermined time 
period. Failure to achieve adequate control by medical means, particularly in patients with 
large tumors, may be an indication for relatively urgent surgery as the only mechanism for 
controlling the excessive catecholamine production. Also, catecholamine-induced 
cardiomyopathy, as well as ST and T-wave abnormalities appear to have little advantage in 
attempting to control them with medical management prior to tumor excision. These 
changes generally regress once the catecholamine source is removed (James, 2010).  
Alpha-adrenergic blockade attenuates or prevents catecholamine-induced vasoconstriction, 
leading to decreased blood pressure as well as to expansion of the blood volume. 
Satisfactory alpha blockade is implied if the hematocrit decreases by about 5%, for example 
from 45% to 40%. Serial monitoring of the hematocrit is a useful method of evaluating the 
adequacy of intravascular volume expansion. Normalization of the intravascular blood 
volume and blood pressure by the alpha adrenergic blockade before surgery can decrease 
the risk of intraoperative hypertension during manipulation of the tumor, and may even 
decrease the degree of hypotension following excision of the tumor. Continuation of alpha 
adrenergic blockade therapy until the day of surgery is recommended in order to minimize 
the hypertensive response during surgery. Also, because of the expanded blood volume, 
concern that sustained alpha blockade could contribute to refractory hypotension when 
vascular isolation of the tumor is accomplished has not been substantiated (Stoelting & 
Dierdorf, 1993). 
5. Undiagnosed pheochromocytoma 
The classic symptoms of pheochromocytoma consist of the triad of excessive sweating, 
headache and palpitation, in addition to paroxysmal hypertension. However, all three 
symptoms occur together in less than 50% of patients. Also, hypertension may be sustained 
in 50% of patients who will be managed as essential hypertension. Also, patients who 
present with anxiety, palpitation, sweating and tremors may be misdiagnosed as stressed or 
menopausal. Abdominal pain, presumably due to bowel ischemia may lead to the erroneous 
diagnosis of acute abdomen. Hyperglycemia may occur and the patient is diagnosed as 
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diabetic (James, 2010). In all these situations, the diagnosis of pheochromocytoma may be 
missed, and hence the patient can develop severe pheochromocytoma crisis during 
incidental surgery or during pregnancy. 
Anesthesia and surgery in unsuspected cases have a high reported mortality. In a 
postmortem series, 27% of patients with undiagnosed pheochromocytoma died during or 
shortly after surgery (Sutton et al, 1981). Headache, palpitation, sweating and hypertension 
are considered to be 90% predictive of pheochromocytoma (Bravo & Gifford, 1984). In 
practice, such symptoms are often dismissed as psychologic or stress related, and the 
diagnosis may be missed until the patient presents with hypertension. Also, excess 
catecholamines produce hyperglycemia, which may be mistaken for insulin-deficient 
diabetes mellitus. Even worse, patients may suffer a whole series of major cardiovascular 
“events” only to suffer an unheralded intraoperative pheochromocytoma crisis (Hull & 
Batchelor, 2003). 
6. Pheochromocytoma crisis 
Although less than 0.1% patients with hypertension actually have a pheochromocytoma, 
nearly 50% of deaths in patients with unsuspected pheochromocytoma occur during 
anesthesia and surgery or during parturition (Kirkendahl et al., 1965). 
The factors triggering intraoperative pheochromocytoma crisis can be attributed to excessive 
release of catecholamines from the undiagnosed tumor secondary to anxiety of the awake 
patient, or secondary to light general anesthesia during surgery (Table 2). 
 
_________________________________________________________________________________ 
 Anxiety of the awake patient 
 Light anesthesia during tracheal intubation and surgery 
 Mechanical Factors 
 Straining 
 Scrubbing 
 Abdominal manipulations of the tumor 
 CO2 insufflation during laparoscopy 
 Excessive uterine contractions or fetal movements 
 Excessive uterine contractions or fetal movements during pregnancy 
_________________________________________________________________________________ 
Table 2. Factors precipitating pheochromocytoma crisis. 
Excessive release of catecholamines may be also drug-induced secondary to histamine 
release, dopamine receptor blockade, or sympathomimetic action (Table 3). 
In addition, excessive release of catecholamines from the pheochromocytoma may be 
attributed to mechanical factors such as squeeze of the tumor during straining, positioning 
of the patient, by scrubbing, by intraperitoneal carbon dioxide insufflations during 
laparoscopy, or by direct manipulation of the tumor. It should be also remembered that 
radiocontrast media has been also associated with pheochromocytoma crisis. 
In the pregnant patient, having pheochromocytoma, excessive uterine contractions or fetal 
movements, as well as normal vaginal delivery or Cesarean section may precipitate the 
crisis; the symptoms and signs may mimic that of severe preeclampsia. However, 
preeclampsia is associated with hypertension and proteinuria usually after the 20th week of 
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gestation, while pheochromocytoma is rarely associated with proteinuria and may cause 
hypertension throughout pregnancy (Mudsmith et al., 2006). 
 
____________________________________________________________________ 
Anticholinergic drugs 
 e.g. atropine 
Sympathomimetic drugs 
 e.g. pancuronium 
Histamine releasing drugs 
 e.g. morphine 
  atracurium, mivacurium 
Dopamine receptor blocker 
 e.g. droperidol (inhibits reuptake of catecholamines) 
Catecholamine-sensitizing anesthetics 
 e.g.  halothane 
  desflurane 
____________________________________________________________________ 
Table 3. Drugs precipitating pheochromocytoma crisis. 
The perioperative pheochromocytoma crisis may mimic other conditions such as thyroid 
storm (Hirvonen et al.,2004) or malignant hyperthermia (Crowley et al.,1988; Allen & 
Rosenberg, 1990). However, the absence of any increase of end-tidal CO2, the lack of 
rigidity, and the near limited increase in temperature may exclude the diagnosis of 
malignant hyperthermia. The presentation of thyroid storm usually includes fever and 
tachycardia, with infection commonly being a precipitating factor. Profuse sweating with a 
high fever out of proportion to the infection may be a due to the presence of a thyroid storm. 
Systolic hypertension and widened pulse pressure is also a common occurrence. Dramatic 
changes in heart rate and/or blood pressure should alert the anesthesiologist to consider 
pheochromocytoma crisis as a possible cause. However, circulatory shock and/or 
pulmonary oedema may be the first manifestation of undiagnosed pheochromocytoma (3). 
The anesthesiologist faced with a patient developing severe hypertension which may 
alternate with hypotension, with developing tachycardia, sweating, heart failure, 
pulmonary edema and acidosis should consider the diagnosis of pheochromocytoma. 
Another sign which may help to confirm the diagnosis is pupillary dilation due to high 
levels of catecholamines (Larson & Herman, 1992). Emergency treatment will usually 
involve shot-acting vasodilator such as the ┙-adrenergic blocker phentolamine. In the case 
of epinephrine-secreting tumor, the severe tachycardia can be controlled by the short-acting 
and selective B1-adrenergic blocker esmolol. 
7. Incidental surgery 
Occasionally, patients undergoing incidental surgery are found to have undiagnosed 
pheochromocytoma. This may occur when a tumor is found by the surgeon. Also, dramatic 
changes in heart rate and/or blood pressure should alert the anesthesiologist to consider 
pheochromocytoma as a cause. This will require judicious use of short-acting vasodilator 
drugs such as phentolamine or sodium nitroprusside to control the hypertension. Whenever 
hypertension is associated with extreme tachycardia, the use of short-acting and selective 
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┚1-adrenergic blocker such as esmolol may be administered. Except when there is extreme 
tachycardia, the use of ┚ -blockade in this acute situation without previous ┙-blockade is 
best avoided. Where surgery can be reasonably be aborted, that is likely to be the wise 
option (Hull & Batchelor, 2003). 
7.1 Case report (Siddik-Sayyid et al.,2007) 
A 43-year-old female patient was admitted to the hospital for right modified radical 
mastectomy. She had a past history of headache and palpitations with no hypertension: her 
preoperative blood pressure (BP) was 130/80 mmHg and her heart rate (HR) was 80 
beats/min. Preoperative electrocardiogram and chest x-ray were normal. General anesthesia 
was induced with propofol, 2 mg/kg, fentanyl, 2 µg/kg, and cisatracurium, 0.15 mg/kg, 
and was maintained with isoflurane in a mixture of nitrous oxide and oxygen (2:1) by using 
intermittent positive-pressure ventilation. Thirty minutes after the start of surgery, the 
patient developed severe hypertension (BP 230/135 mmHg) and marked tachycardia (HR 
160-180 beats/min). The anesthetic level was deepened by increasing the concentration of 
isoflurane and by additional doses of fentanyl (3 µg/kg) and midazolam (2 mg). Also, 
intravenous boluses of nitroglycerin (100 µg) and propranolol (1 mg) were given. The BP 
decreased to 100/50 mmHg and the HR to 130 beats/min. Right mastectomy and lymph 
node dissection were continued. Twenty minutes later, oxygen saturation as monitored by 
pulse oximetry dropped to 92%. Also, chest auscultation revealed diffuse crepitations over 
both lung fields. Arterial blood gas analysis showed hypoxemia associated with 
uncompensated metabolic acidosis. Esophageal temperature increased to 38.5oC. Surgery 
lasted for 2 hours, and the patient was transferred intubated and ventilated to the intensive 
care unit for further management. 
A chest x-ray showed widespread alveolar infiltration suggestive of pulmonary edema. 
Echocardiography revealed severe global hypokinesia of the left ventricle with an estimated 
ejection fraction of 20% to 25%. Cardiac catheterization showed normal coronaries. The 
patient’s clinical condition deteriorated rapidly; she developed MOF including acute renal 
failure, hepatitis, pancreatitis, and disseminated intravascular coagulation. A computed 
tomography (CT) scan of the abdomen showed a 5.8cm mass in the left adrenal region, 
which raised suspicions of a pheochromocytoma. Spot urine vanillylmandelic acid (VMA) 
was 50.8 µg/mg of creatinine (normal range in this laboratory is 10.4 µg/mg of creatinine) 
with a creatinine of 12.6 mg/dl. A presumptive diagnosis of pheochromocytoma was made. 
The patient remained on mechanical ventilation and required daily hemodialysis. She was 
transfused with packed cells, platelets, and fresh frozen plasma. Blood cultures grew no 
pathogens; however, she was started on imipenem and vancomycin. The patient had 
marked fluctuations of BP between 85/55 mmHg and 220/120 mmHg, which necessitated 
aggressive inotropic support alternating with the combination of nitroglycerin and sodium 
nitroprusside infusion. A pulmonary artery catheter was inserted and showed a cardiac 
index varying between 2.3 and 3.0 L/min/m2 and a pulmonary artery pressure varying 
between 26/11 and 43/22 mmHg. During the following days, the patient’s temperature 
normalized, and there was improvement of the pulmonary, hepatic, pancreatic, and 
coagulation systems. However, the blood urea nitrogen and creatinine remained markedly 
elevated despite daily hemodialysis for 3 to 4 hours. On the 13th day after the surgery, it was 
decided to proceed with an emergency excision of the pheochromocytoma.  
Two days before surgery, prazosin was started at a dose of 1 mg orally 3 times a day. The 
antihypertensive regimen was maintained until the morning of surgery. The hemodynamic 
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profile before anesthesia showed BP of 140/70 mmHg, heart rate of 120 beats/min, and 
central venous pressure of 12 mmHg. In the operating room, the patient was monitored 
continuously with 5-lead electrocardiogram, pulse oximetry, capnography, intraarterial 
blood pressure, and central venous pressure measurements. Anesthesia was induced with 
propofol, 1 mg/kg, midazolam, 0.03 mg/kg and cisatracurium, 0.2 mg/kg, and a 
remifentanil infusion was initiated at a rate of 2 µg/kg.min. Anesthesia was maintained 
with 2% to 5% isoflurane in a mixture of air/oxygen (3:1), remifentanil, 1 to 2 µg/kg/min, 
and incremental doses of cisatracurium. Blood volume was expanded carefully throughout 
the procedure by normal saline solution to maintain an adequate central venous pressure. 
Through a midline abdominal incision, the left kidney was exposed, and the patient 
underwent resection of her left adrenal gland. During manipulation of the tumor, the BP 
went up to 220/120 mmHg and required increasing concentrations of isoflurane up to 6% 
end-tidal) and nitroprusside (1-3 µg/kg/min). The patient also developed severe 
tachycardia, which was controlled by intravenous esmolol, 0.5 mg/kg, followed by an 
intravenous infusion at a rate of 25 µg/kg/min. Ligation of the efferent vein of the tumor 
resulted in an abrupt fall in BP to 50/20 mmHg, which was managed with a norepinephrine 
infusion and rapid infusion of normal saline solution and colloid solution (Hemaccel: 
Hoechst Marion Roussel, Frankfurt am Main, Germany). Postoperatively, the patient made a 
quick recovery, and her trachea was extubated after 48 hours. Hemodialysis support was 
discontinued after 4 days. Pathology of the resected tissue confirmed the presence of 
encapsulated pheochromocytoma with focal areas of hemorrhage. 
8. Pheochromocytoma during pregnancy (Hamilton,1997; Takahashi et 
al.,1998; Strachan et al., 2000; Mudsmith et al., 2006) 
Pheochromocytoma is a dangerous condition, particularly in pregnancy, when it is difficult 
to diagnose, uncommon and has often been confused with preeclampsia. 
Pheochromocytoma during pregnancy may mimic the usual symptoms and signs of 
preeclampsia, either as simple hypertension or fulminant eclampsia.  
Paroxysmal attacks during pregnancy may be precipitated by postural changes, the 
mechanical effect of the gravid uterus in the last trimester, uterine contractions during labor 
and increased fetal movements. Pheochromocytoma can mimic the symptoms and signs of 
preeclampsia and is therefore often missed. However, hypertension associated with 
pheochromocytoma is seldom accompanied by oedema or proteinuria, while glycosuria is 
often present. 
The use of intravenous labetalol or hydralazine is well established in preeclampsia, and its 
use in combination with magnesium sulphate has been described in patients with 
pheochromocytoma. The pharmacodynamic properties of magnesium sulphate (direct 
vasodilator, inhibition of catecholamine release from the adrenal medulla) make it useful for 
the management of pheochromocytoma(James, 2010). Magnesium also has powerful anti-
arrhythmic action in the presence of catecholamines. 
When pheochromocytoma develops in pregnancy, there is a high risk of maternal and/or 
fetal mortality. Even vigorous fetal movements may be associated with hypertensive crisis. 
For cases diagnosed during pregnancy, there is a clear choice between early intervention 
and conservative management until fetal viability permits elective cesarean section. 
Hamilton et al reported the use of prazosin and propranolol followed by surgical removal of 
a pheochromocytoma at 7 weeks gestation, followed by an uneventful pregnancy and 
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delivery at 37 weeks. Nitroglycerine was used to control hypertension during surgery in 
preference to sodium nitroprusside on the grounds that the latter may reduce uterine blood 
flow. Also, phenoxyhenzamine is avoided during early pregnancy since it may have 
teratogenic effect. 
When the pheochromocytoma is diagnosed later at 29 weeks gestation, conservative 
treatment using labetalol may be continued until 35 weeks when the fetus is delivered and 
the tumor removed at the same operation. When the parturient commences labor with 
unsuspected pheochromocytoma, the hypertension may be managed by intravenous 
phentolamine or a combination of magnesium and hydralazine until delivery, followed by 
oral preparation of pheochromocytoma for delayed formal resection. 
9. Multicentric pheochromocytoma (Stoelting & Dierdorf, 1993; Wahlen et al., 
1992; Isselbacher et al., 1994; Baraka et al., 2002) 
Pheochromocytoma is a rare disorder occurring in 0.1% of the hypertensive population. It 
consists of a catecholamine secreting tumor, arising from chromaffin cells, either in the 
adrenal medulla in 75-85% of patients or in an extraadrenal location. Extraadrenal sites 
include any organ that contains paraganglionic tissue, along the paravertebral sympathetic 
chain, extending from the base of the skull to the pelvis. Most of the extraadrenal 
pheochromocytomas or paragangliomas are located below the diaphragm. 
Pheochromocytoma hemodynamic crisis may occur in patients with undiagnosed 
pheochromocytoma undergoing incidental surgery, in pregnant patients, as well as in 
patients with multicentric extraadrenal pheochromocytoma. 
Extraadrenal sites include any organ that contains paraganglionic tissue, along the 
paravertebral sympathetic chain extending from the base of the skull to the pelvis. Most of 
the extra adrenal pheochromocytomas or paragangliomas are located below the diaphragm. 
Approximately 18% of pheochromocytomas are extraadrenal. The most common location is 
the superior aortic region between the diaphragm and the inferior renal poles, in and 
around the renal hilum and accounts for approximately 46% of the extra adrenal tumors. 
Extra adrenal tumors in the inferior paraortic area between the lower renal poles and the 
aortic bifurcation have constituted 24% of the cases. Most of these tumors have arisen from 
the organ of Zucherkandl which consists of paraganglia found in the retroperitoneal region 
along the aorta around the inferior mesenteric artery.  
Most of extraadrenal pheochromocytoma secretes norepinephrine exclusively. If both 
norepinephrine and epinephrine are secreted, then the pheochromocytoma is very likely to 
be adrenal or Zucherkandl in origin. Serious hemodynamic fluctuations may occur during 
manipulations of the tumor of the organ of Zucherkandl which may be attributed to 
excessive catecholamine release secondary to its larger size and its more difficult resection. 
The present report describes the perioperative anesthetic management and the serious 
hemodynamic fluctuations observed in a patient undergoing resection of recurrent 
retroperitoneal multicentric extraadrenal pheochromocytomas. The report also shows that 
variable hemodynamic responses may occur during surgical excision of multicentric 
pheochromocytomas, suggesting that these tumors may be quite different functionally even 
if they grow concomitantly in the same patient. 
9.1 Case report (Baraka et al. 2002) 
The patient, a 28-year-old man, underwent at 12 year of age a laparotomy for the excision of 
an extraadrenal infrarenal pheochromocytoma adjacent to the lower pole of the left kidney. 
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He had been free of symptoms until three months before presentation, when he presented 
with paroxysmal headache, occasional sweating, palpitations, and abdominal discomfort. 
He was found to have a blood pressure (BP) of 200/100 mmHg. A 24-hr-urine collection 
showed catecholamines 5076 µg.24 hr-1 (normal <25µg.24 hr-1), vanillylmandylic acid of 13 
mg.24 hr-1 (normal < 8 mg.24 hr-1) and metanephrines 6009 µg.24hr-1 (normal < 900 µg.24 hr-
1). Computed tomography of the abdomen revealed two retroperitoneal masses, one 
adjacent to the lower pole of the right kidney and a second larger mass located at the aortic 
bifurcation in the region of the organ of Zuckerkandl. 
The patient was prepared preoperatively for two weeks with prazosin 1 mg po q six hours 
(because of the unavailability of phenoxyenazmine in our hospital), and propranolol 10 mg 
tid. The BP stabilized at 120/90 mmHg supine and standing, with a regular heart rate (HR) 
of 68 beats.min-1. Electrocardiogram (ECG) showed normal sinus rhythm, with non-specific 
T wave changes in V1-V4 leads. Hematocrit (Hct) was 43% and blood sugar level was 
normal. 
The patient was premedicated with diazepam 5 mg po. In the operating room, he was 
monitored continuously with a 5-lead ECG, pulse oximetry, capnography, intraarterial BP 
measurement, and pulmonary artery (PA) catheter. Prior to induction of anesthesia, BP was 
145/90 mmHg and HR was 75 beats.min. General anesthesia was induced with iv lidocaine 
1 mg.kg, propofol 3 mg.kg, fentanyl 2 µg/kg and rocuronium 1 mg.kg. The patient was 
ventilated with 4% sevoflurane in 100% O2 prior to proceeding with laryngoscopy and 
tracheal intubation. Anesthesia was then maintained with 4-8% sevoflurane in 100% O2, and 
by incremental doses of fentanyl and rocuronium, as needed. Blood volume was expanded 
throughout the procedure by lactated Ringer’s solution and by Haemaccel ® (Hoechst 
Marion Rousse. Frankfurt am Main, Germany) to maintain adequate central venous 
pressure and urine output. 
Through a midline abdominal incision, the right kidney was exposed and a mass was 
visualized, medial to the lower pole of the kidney, inferior to the renal helium and lateral to 
the vena cava. Dissection of the tumor from its surrounding structures was performed 
easily. Minimal hemodynamic changes occurred and responded to increasing 
concentrations of sevoflurane. 
The tumor of Zuckerkandl was overlying and adherent to the bifurcation of the aorta. 
Surgical dissection of the tumor was difficult and associated with excessive blood loss. 
Manipulation of the tumor resulted in severe hypertensive episodes with BP ranging from 
200/100 to 320/120 mmHg. Systemic hypertension was associated with elevation of PA 
pressure. Surgery was interrupted temporarily; sodium nitroprusside was infused in 
increasing doses up to 2µg.kg-1.min-1, and two doses of iv phentolamine 5 mg were 
administered. Hypertension also necessitated the bolus administration of esmolol 0.5 mg.kg-
1 iv to be followed by an iv infusion of 30 mg esmolol over 20 min. 
Ligation of the efferent vein of the tumor immediately resulted in a fall in BP which reached 
70/50 mmHg. This hypotension was treated by decreasing the concentration of sevoflurane, 
as well as by rapid iv infusion of lactated Ringer’s solution and 2 U of blood. In addition, a 
norepinephrine infusion (0.05 µg.kg.min) was required for 20 min. Thereafter, BP returned 
to normal without further treatment. The patient was kept sedated, intubated and 
transferred to the intensive care unit with a BP of 130/75 mmHg and a HR of 85 beats.min. 
His postoperative course was smooth and uneventful. 
Pathology examination of the resected tumors confirmed the diagnosis of 
pheochromocytoma; the first mass was slightly smaller (5 x 4 x 4 cm vs 6 x 4 x 3.5 cm) and 
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weighed less (43 g vs 46 g) than the second tumor. The two tumors showed no evidence of 
necrosis or unusual meiotic activity. 
10. Pheochromocytoma cardiomyopathy and multiple organ failure 
A high mortality rate has been reported in pheochromocytoma patients with catecholamine-
induced cardiomyopathy presenting symptoms of congestive heart failure, arrhythmia, 
acute pulmonary oedema and nonspecific EKG changes, as well as in pheochromocytoma 
complicated with multiple organ failure. 
Echocardiography may reveal global cardiac hypokinesia secondary to cardiomyopathy in 
25% to 50% of pheochromocytoma as a result of sustained exposure of the myocardium to 
high levels of catecholamines. Studies have shown a global reduction in myocardial pump 
function caused by a down-regulated ┚-adrenergic receptors and a net reduction in viable 
myofibrils. Rabits’ hearts with catecholamine-induced cardiomyopathy have shown a 
reduced inotropic sensitivity to noradrenaline, and also a reduced response to calcium 
chloride. The pathogenesis of catecholamine-induced cardiomyopathy is probably 
multifactorial. Catecholamine-induced vasospasm leading to hypoxia is implicated. Excess 
noradrenaline also induces changes in permeability of the sarcolimmal membrane leading to 
increased calcium influx. Also, it has been proposed that the injury process might involve 
release of free radicals (Sardesai et al.,1990; Gilsanz et al.., 1983; Takaror et al., 1987; Fripp et 
al., 1981). Left atrial enlargement secondary to catecholamine-induced left ventricular 
diastolic dysfunction is quite common (around 20%), but seldom poses a management 
problem unless accompanied by left ventricular systolic dysfunction. Left ventricular 
hypertrophy is frequently seen, as are ST and T-wave abnormalities. These appear to be 
little advantage in attempting to correct these changes by medical management prior to 
tumor excision. These changes generally regress once the excess catecholamines source is 
removed. Left ventricular failure and pulmonary edema may be present, particularly if the 
patient has developed signs of catecholamine-induced cardiomyopathy (James, 2010). 
Multiple organ failure (MOF) may be the initial presentation, and is called 
pheochromocytoma multisystem crisis. MOF may result from the high levels of circulating 
catecholamines, which can trigger excessive vascular spasm, volume contraction, platelet 
aggregation and thrombosis. The splanchnic vessels are highly susceptible to catecholamine-
induced vasoconstriction, and hence the ischemic gut mucosa may allow bacterial 
translocation or the passage of endotoxins across the intestinal barrier to extraintestinal sites 
including the lung which is the first organ to fail. Also, acute renal failure can be attributed 
to acute tubular necrosis because of the combination of cardiogenic shock reducing the renal 
perfusion, associated with renal vasoconstriction induced by a surge of catecholamines 
(Sardesai et al.,1990; Gilsanz et al.., 1983; Takaror et al., 1987; Fripp et al., 1981). 
Gut-derived factors, contained primarily in the mesenteric lymph rather than the portal 
system, potentiate the development of distant multiple organ failure. Because the lung is the 
first organ exposed to mesenteric lymph, via the thoracic duct and the subclavian vein, the 
lung is generally the first organ to fail in severely injured patients. The role of the gut injury 
and loss of gut barrier function contributes to the development of a systemic inflammatory 
state and distant organ injury (Fukushima et al.,1998). 
During the decade from 1985 to 1995, gut barrier and the ensuing translocation of bacteria 
and endotoxins gained acceptance as a major contribution to the development of multiple 
organ dysfunction syndrome (MODS). It now appears that pheochromocytoma similar to 
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shock, trauma, or sepsis-induced gut injury can result in the gut becoming a cytokine-
generating organ, and that the mesenteric circulation can become a priming bed for 
circulating neutrophils. Many of the same insults that cause intestinal mucosal injury and 
promote bacterial translocation also appear able to induce the gut and the gut-associated 
lymphatic tissue to produce cytokines and other inflammatory mediators that may 
contribute to MODS (Fukushima et al., 1998; Deitch,2001). 
In a review of 54 autopsy-proven cases of unsuspected pheochromocytoma seen at the 
Mayo Clinic over a 50-year period, hypertensive or hypotensive crisis precipitated by 
surgery for unrelated conditions was a common cause of death. Intraoperative deaths have 
been ascribed variously to ventricular arrhythmias, wide fluctuations in systemic blood 
pressure, myocardial infarction, acute pulmonary oedema, and subarachnoid hemorrhage 
(St. John Sutton, et al.,1981). Barale et al., 1978 described two patients with circulatory shock, 
vasoconstriction, and pulmonary edema as the first manifestation of undiagnosed 
pheochromocytoma (Barale et al.,1978). Also, MOF may be the initial presentation of 
undiagnosed pheochromocytoma and has a poor prognosis (Barale et al.,1978; Kohle et 
al.,2001). Newell et al.,1988 reported 3 patients with unusual presentations of 
pheochromocytomas, which they called “pheochromocytoma multisystem crisis”, a tetrad 
of symptoms including MOF, encephalopathy, high fever, and severe derangements in BP 
consisting of hypertension and/or hypotension. Siddik-Sayyid et al.,2007 reported a patient 
with an undiagnosed pheochromocytoma undergoing radical mastectomy; the patient 
developed intraoperative severe hemodynamic changes and pulmonary oedema, 
complicated by postoperative MOF; the postoperative hemodynamic instability and the 
persistent renal failure rapidly recovered after excision of the pheochromocytoma (Siddik-
Sayyid et al., 2007). 
Management of intraoperative pheochromocytoma crisis in patients undergoing incidental 
surgery consists of elimination of the triggering factors, as well as controlling hypertension 
by the administration of short-acting vasodilators such as the alpha-adrengergic blocker 
phentolamine, or sodium nitroprusside infusion. Whenever hypertension is associated with 
severe tachycardia, beta-adrenergic blocker can be administered; the short-acting and 
selective beta 1 blocker esmolol is preferred to the long-acting and nonselective propranolol. 
The administration of beta-adrenergic blocker without prior ┙-adrenergic blockade may be 
complicated by cardiac failure and pulmonary oedema secondary to its negative inotropic 
effect on the heart, associated with an increased after load. Initiation of nonselective beta 
blocker therapy without preceding alpha blockade in a patient with pheochromocytoma my 
precipitate a crisis with hemodynamic collapse. Nonselective beta blockade leads to loss of 
beta 2 receptor-mediated vasodilation, while the unopposed effects of alpha receptors 
causes vasoconstriction, resulting in increased after load, causing myocardial dysfunction 
and pulmonary oedema (Siddik-Sayyid et al., 2007). Thus, nonselective beta blockers should 
be avoided in any patient who could conceivably have a pheochromocytoma, until that 
possibility has been excluded. Also, unexplained cardiopulmonary dysfunction, and 
pulmonary oedema after the institution of beta blockade, should alert the anesthesiologist to 
the possibility of a pheochromocytoma (Sibal et al., 2006).  
In patients with undiagnosed pheochromocytoma undergoing incidental surgery, many 
authors recommend urgent operation whenever their condition deteriorates despite 
maximal medical therapy. Newell et al.,1988 recommend urgent adrenalectomy when 
multisystem injury is present and in cases of progressive deterioration despite medical 
therapy. Also, Wood (Case 6-1986) stated that preparation for operation involves a balance 
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between severity of the illness and quality of ┙-blockade, and suggested that certain patients 
undergo surgical tumor excision with incomplete ┙--blockade. Freier et al.,1980 
recommended urgent tumor excision after brief attempts at medical stabilization in patients 
presenting with alternating hypertension or hypotension, severe tachycardia, cardiac 
arrhythmias, encephalopathy, and renal failure.  
11. Conclusion 
In conclusion, patients with undiagnosed pheochromocytoma undergoing incidental 
surgery may develop intraoperative hemodynamic crisis complicated by postoperative 
multiple organ failure. 
Management of intraoperative pheochromocytoma crisis consists of elimination of the 
triggering factors, as well as the administration of short-acting vasodilators such as the 
alpha-adrenergic blocker phentolamine, or sodium nitroprusside infusion. The 
administration of beta adrenergic blocker without prior ┙-adrenergic blockade may be 
complicated by cardiac failure and pulmonary edema secondary to its negative inotropic 
effect associated with an increased after load. 
When the pheochromocytoma is surgically accessible during incidental surgery as 
laparotomy, the surgeon may be tempted to excise the tumor. However, tumor handling in 
unprepared patients may result in dramatic increases in arterial blood pressure followed by 
intractable hypotension after tumor excision.  A safer option is planned resection of the 
pheochromocytoma after confirmation of the diagnosis and optimal preoperative 
pharmacologic preparation. However, urgent adrenalectomy is recommended whenever 
multisystem injury deteriorates despite maximal medical therapy. 
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